Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Double-Blind Randomized Controlled Trial of Acute-Course of Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents

To see complete record on, please visit this link

Id: NCT04592809

Organisation Name: University of Texas Southwestern Medical Center

Overal Status: Not yet recruiting

Start Date: December 6, 2022

Last Update: June 30, 2022

Lead Sponsor: University of Texas Southwestern Medical Center

Brief Summary: The study design is a double-blind, randomized, active-control trial of adolescents (ages 13-18 years) with recent suicidal behaviors (suicide attempt or increased suicidal ideation). All participants will be treated through a suicide prevention IOP (typically 6-8 weeks), as well as clinically indicated psychosocial and/or psychopharmacological treatments. Ketamine/midazolam treatment will occur twice weekly during the first two weeks of the study, followed by weekly assessments through week 12.

  • Suicide, Attempted
  • Suicide and Depression
  • Suicide Threat

Total execution time in seconds: 0.30687999725342